Icure Pharmaceutical Incorporation Logo

Icure Pharmaceutical Incorporation

Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.

175250 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 봉은사로104길 10 7층, 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Icure Pharmaceutical Incorporation is a biopharmaceutical company specializing in the research, development, and commercialization of products based on its Transdermal Drug Delivery System (TDDS) technology. Established in 2000, the company develops innovative new drugs, including transdermal patches for dementia and Parkinson's disease. Icure also operates a cosmeceutical business, leveraging its pharmaceutical expertise to offer Original Design Manufacturing (ODM) and Original Brand Manufacturing (OBM) services for cosmetics.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Icure Pharmaceutical Incorporation and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-17 00:00
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상 결정)
Korean 4.9 KB
2025-09-17 00:00
Delisting Announcement
주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)
Korean 4.7 KB
2025-09-16 00:00
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
Korean 14.7 KB

Automate Your Workflow. Get a real-time feed of all Icure Pharmaceutical Incorporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Icure Pharmaceutical Incorporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
H. Lundbeck A Logo
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark HLUN
Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea 145020
Human Stem Cells Institute PJSC Logo
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation ISKJ
HUMASIS CO., LTD. Logo
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea 205470
Humedix Co., Ltd. Logo
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea 200670
HUONS CO., LTD. Logo
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea 243070
Huons Global Co., Ltd. Logo
Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.
South Korea 084110
Hong Kong N/A
HWAIL PHARM. CO., LTD Logo
Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.
South Korea 061250
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL

Talk to a Data Expert

Have a question? We'll get back to you promptly.